Feb. 25 (UPI) --A new, wide-ranging review of existing scientific data released Tuesday is pointing to the possibility that dozens of commonly prescribed drugs could adversely affect brain development ...

A powerful editorial published today in Brain Medicine raises alarm about a previously overlooked threat to brain development and public health: the disruption of sterol biosynthesis by common ...

A new study published in Developmental Cognitive Neuroscience provides initial evidence that differences in brain chemistry during adolescence may help explain why some teens are more likely to ...

A recent Northwestern Medicine study has identified novel neural circuits modulated by the diabetes and obesity-management ...

Researchers have identified a rare type of brain cell whose overactivity may contribute to schizophrenia-like symptoms, such as cognitive deficits and disrupted sleep.

The U.S. Food and Drug Administration (FDA) has granted rare pediatric drug designation for iopofosine-131 in inoperable relapsed or refractory pediatric high-grade glioma (pHGG), according to a news ...